Top Stock Analyst Reports For Pfizer, Wells Fargo & SAP

 | Jan 22, 2020 12:41AM ET

Wednesday, January 22, 2020

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Pfizer (PFE), Wells Fargo (WFC) and SAP SE (DE:SAPG) (SAP). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

You can see

Today's Must Read/h6

Featured Reports/h6

Per the Zacks analyst, salesforce is gaining from its diverse cloud offerings, which are helping it win customers globally.

Per the Zacks analyst TOTAL's focus to develop LNG assets globally and its strong production growth through new startup are going to boost its performance.

Per the Zacks analyst, higher demand for newer drugs should drive Lilly's sales amid generic competition for drugs like Cialis, rising pricing pressure and currency headwinds.

The Zacks Analyst believes that improving economy and initiatives to expand market share have helped U.S. Bancorp witness growth in loan and deposits.

Per the Zacks analyst, Sinopec's discovery of attractive and economically-viable gas reserves in Sichuan Basin will drive production.

The Zacks analyst appreciates Caterpillar's proactive measures to lower production and control costs in the wake of weak demand.

Per the Zacks analyst, Zoetis companion animal business driven by higher sales of Apoquel and Simparica should maintain growth amid competition.

New Upgrades/h6

Per the Zacks analyst, Target's focus on enhancing omni-channel capacities, coming up with new brands, remodeling stores and expanding same-day delivery options are likely to fuel top-line growth.

The Zacks analyst is bullish on STERIS's strong performance of Healthcare Specialty Services segment and continued benefits obtained from the Synergy Health integration.

Per the Zacks Analyst, EchoPark expansion is likely to boost Sonic Automotive's top-line growth. Further, its franchise business is also expected to grow organically via accretive acquisitions.

New Downgrades/h6

Per the Zacks Analyst, low 737 deliveries as a result of the worldwide grounding of 737 Max jets hurts sales.

Per the Zacks analyst, lower interest rates will put pressure on Associated Banc-Corp's net interest margin.

Headwinds in Mainland China dented Nu Skin's top line in third-quarter 2019. Per the Zacks analyst, the dismal performance along with currency volatility led to weak projections for 2019.


Get The News You Want
Read market moving news with a personalized feed of stocks you care about.
Get The App

undefined Zacks Investment Research

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Sign out
Are you sure you want to sign out?
NoYes
CancelYes
Saving Changes